IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0279090.html
   My bibliography  Save this article

Disease Management Program in patients with type 2 diabetes mellitus, long-term results of the early and established program cohort: A population-based retrospective cohort study

Author

Listed:
  • Regina Riedl
  • Martin Robausch
  • Andrea Berghold

Abstract

Background: The aim of this study was to evaluate the long-term follow up of the early and the effectiveness of the established program of the Austrian Disease Management Program (DMP) ‘Therapie aktiv—Diabetes im Griff’ for patients with type 2 diabetes mellitus concerning mortality, major macrovascular complications, costs and process quality of care parameters. Methods: We conducted a propensity score matched cohort study based on routine health insurance data for type 2 diabetic patients. The observational period from the matched early program cohort starts from January 1, 2009 to December 31, 2017 and includes 7181 DMP participants and 21543 non-participants. In the established matched program cohort, 3087 DMP participants and 9261 non-participants were observed within January 1, 2014 to December 31, 2017. Results: In the early program cohort, 22.1% of the patients in the DMP-group and 29.7% in the control-group died after 8 years follow-up (HR = 0.70; 95% CI: 0.66–0.73). A difference of € 1070 (95% bootstrap-T interval: € 723 - € 1412) in mean total costs per year was observed. In the established program cohort, 10.4% DMP participants died 4 years after enrollment, whereas in the control-group 11.9% of the patients died (HR = 0.88, 95% CI: 0.78–0.99). Healthcare utilization is higher in the DMP-group (75%-96%) compared to the control-group (63%-90%). Conclusions: The 8-year long-term follow up of the DMP program showed a relevant improvement of survival and healthcare costs of patients with type 2 diabetes. The established program cohort had improved survival and quality of care. Our findings indicate that the DMP "Therapie aktiv" provides a long-term advantage for type 2 diabetes patients.

Suggested Citation

  • Regina Riedl & Martin Robausch & Andrea Berghold, 2022. "Disease Management Program in patients with type 2 diabetes mellitus, long-term results of the early and established program cohort: A population-based retrospective cohort study," PLOS ONE, Public Library of Science, vol. 17(12), pages 1-15, December.
    • Handle: RePEc:plo:pone00:0279090
    DOI: 10.1371/journal.pone.0279090
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279090
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0279090&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0279090?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Manning, Willard G. & Basu, Anirban & Mullahy, John, 2005. "Generalized modeling approaches to risk adjustment of skewed outcomes data," Journal of Health Economics, Elsevier, vol. 24(3), pages 465-488, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Courbage, Christophe & Rey, Béatrice, 2012. "Priority setting in health care and higher order degree change in risk," Journal of Health Economics, Elsevier, vol. 31(3), pages 484-489.
    2. Onur Başer & Joseph C. Gardiner & Cathy J. Bradley & Hüseyin Yüce & Charles Given, 2006. "Longitudinal analysis of censored medical cost data," Health Economics, John Wiley & Sons, Ltd., vol. 15(5), pages 513-525, May.
    3. Keane, Michael & Stavrunova, Olena, 2016. "Adverse selection, moral hazard and the demand for Medigap insurance," Journal of Econometrics, Elsevier, vol. 190(1), pages 62-78.
    4. Laurent Carnis & Hamza Achit, 2014. "The injured victim's health care spending: is there an effect of the origin of accident?," Applied Economics Letters, Taylor & Francis Journals, vol. 21(5), pages 350-355, March.
    5. Tor Iversen & Eline Aas & Gunnar Rosenqvist & Unto Häkkinen & on behalf of the EuroHOPE study group, 2015. "Comparative Analysis of Treatment Costs in EUROHOPE," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 5-22, December.
    6. Marcel Bilger & Willard G. Manning, 2015. "Measuring Overfitting In Nonlinear Models: A New Method And An Application To Health Expenditures," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 75-85, January.
    7. Manning, Willard G. & Basu, Anirban & Mullahy, John, 2005. "Generalized modeling approaches to risk adjustment of skewed outcomes data," Journal of Health Economics, Elsevier, vol. 24(3), pages 465-488, May.
    8. Kurt Lavetti & Thomas DeLeire & Nicolas R. Ziebarth, 2023. "How do low‐income enrollees in the Affordable Care Act marketplaces respond to cost‐sharing?," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 90(1), pages 155-183, March.
    9. Juan F Orueta & Arturo García-Álvarez & Manuel García-Goñi & Francesco Paolucci & Roberto Nuño-Solinís, 2014. "Prevalence and Costs of Multimorbidity by Deprivation Levels in the Basque Country: A Population Based Study Using Health Administrative Databases," PLOS ONE, Public Library of Science, vol. 9(2), pages 1-11, February.
    10. Pilny, Adam & Wübker, Ansgar & Ziebarth, Nicolas R., 2017. "Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany," Journal of Health Economics, Elsevier, vol. 56(C), pages 330-351.
    11. Anirban Basu & James J. Heckman & Salvador Navarro-Lozano & Sergio Urzua, 2007. "Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1133-1157.
    12. Mircea Marcu & Caprice Knapp & Vanessa Madden & David Brown & Hua Wang & Phyllis Sloyer, 2014. "Effects of an Integrated Care System on Children with Special Health Care Needs' Medicaid Expenditures," Working Papers 2014-8, University of Alberta, Department of Economics.
    13. Dunn, Abe, 2016. "Health insurance and the demand for medical care: Instrumental variable estimates using health insurer claims data," Journal of Health Economics, Elsevier, vol. 48(C), pages 74-88.
    14. Stefano Calciolari & Aleksandra Torbica & Rosanna Tarricone, 2013. "Explaining the Health Costs Associated with Managing Intracranial Aneurysms in Italy," Applied Health Economics and Health Policy, Springer, vol. 11(4), pages 427-435, August.
    15. Pandey, Anamika & Clarke, Lynda & Dandona, Lalit & Ploubidis, George B., 2018. "Inequity in out-of-pocket payments for hospitalisation in India: Evidence from the National Sample Surveys, 1995–2014," Social Science & Medicine, Elsevier, vol. 201(C), pages 136-147.
    16. Liu, Lei & Conaway, Mark R. & Knaus, William A. & Bergin, James D., 2008. "A random effects four-part model, with application to correlated medical costs," Computational Statistics & Data Analysis, Elsevier, vol. 52(9), pages 4458-4473, May.
    17. Melo, Grace, 2017. "The Impact of NuVal Shelf Nutrition Labels on Consumption: Evidence from Cold Cereal Purchases," 2017 Annual Meeting, February 4-7, 2017, Mobile, Alabama 252421, Southern Agricultural Economics Association.
    18. Frank Windmeijer, 2006. "GMM for panel count data models," CeMMAP working papers CWP21/06, Centre for Microdata Methods and Practice, Institute for Fiscal Studies.
    19. Yilmaz, Hulya & Sazak, Hakan S., 2014. "Double-looped maximum likelihood estimation for the parameters of the generalized gamma distribution," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 98(C), pages 18-30.
    20. Bilger M. & Manning W.G, 2011. "Measuring overfitting and mispecification in nonlinear models," Health, Econometrics and Data Group (HEDG) Working Papers 11/25, HEDG, c/o Department of Economics, University of York.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0279090. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.